Lexicon Pharmaceuticals (LXRX) Accumulated Depreciation & Amortization: 2010-2012
Historic Accumulated Depreciation & Amortization for Lexicon Pharmaceuticals (LXRX) over the last 2 years, with Dec 2012 value amounting to $916,000.
- Lexicon Pharmaceuticals' Accumulated Depreciation & Amortization fell 19.30% to $916,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $4.2 million, marking a year-over-year decrease of 14.26%. This contributed to the annual value of $534,000 for FY2024, which is 3.61% down from last year.
- Latest data reveals that Lexicon Pharmaceuticals reported Accumulated Depreciation & Amortization of $916,000 as of Q4 2012, which was down 13.18% from $1.1 million recorded in Q3 2012.
- Lexicon Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $1.3 million for Q3 2010, and its period low was $916,000 during Q4 2012.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $1.2 million (2011), whereas its average is $1.2 million.
- Data for Lexicon Pharmaceuticals' Accumulated Depreciation & Amortization shows a maximum YoY dropped of 19.30% (in 2012) over the last 5 years.
- Quarterly analysis of 3 years shows Lexicon Pharmaceuticals' Accumulated Depreciation & Amortization stood at $1.3 million in 2010, then decreased by 13.49% to $1.1 million in 2011, then fell by 19.30% to $916,000 in 2012.
- Its Accumulated Depreciation & Amortization was $916,000 in Q4 2012, compared to $1.1 million in Q3 2012 and $1.1 million in Q2 2012.